已收盤 08-15 16:00:00 美东时间
+0.016
+0.90%
An update from CytoMed Therapeutics Limited ( ($GDTC) ) is now available. On Ju...
07-21 22:27
Singapore-based biopharmaceutical company CytoMed Therapeutics Limited has successfully completed dose level 1 of its Phase I ANGELICA Trial, a first-in-human study evaluating allogeneic gamma delta T cells (CTM-N2D) for treating advanced cancers. The trial involves four late-stage cancer patients, with dose level 2 set to begin in the third quarter of 2025. Unlike traditional CAR-T therapies, which use a patient’s own cells, CTM-N2D uses donor-d...
07-21 14:01
An announcement from CytoMed Therapeutics Limited ( ($GDTC) ) is now available....
07-04 04:28
CytoMed Therapeutics (NASDAQ:GDTC) may offer up to $50M in securities under a new shelf registration. Securities may include ordinary shares, warrants, debt, rights, share purchase units, and more. So...
06-14 04:33
CytoMed Therapeutics Limited ( ($GDTC) ) just unveiled an update. CytoMed Thera...
05-16 18:58
CytoMed Therapeutics press release (NASDAQ:GDTC): FY topline income amounted to $624,771 in 2024 compared to $588,423 in 2023. Cash and bank balances amounted to US$3.64 million as of December 31, 20...
04-29 22:10
Kimberly-Clark将继续通过其位于班加罗尔的全球数字技术中心(GDTC)加大对印度的投入。GDTC自2018年成立以来,规模已扩大八倍,重点关注数据与...
2024-12-27 14:41
Kimberly-Clark扩大在印投资 印度班加罗尔2024年12月27日 /美通社/ -- Kimberly-Clark是全球领先的个人和家庭护理必需品供应...
2024-12-27 13:35
Kimberly-Clark Expanding Investments in India BENGALURU, India, Dec. 26, 2024 /PRNewswire/ -- Kimberly-Clark, a global leader in essential personal and family care products, continues to inc...
2024-12-26 18:34